Erste Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $147K | Hold |
|
|||||
|
2025
Q2 | $113K | Hold |
|
|||||
|
2025
Q1 | $339K | Hold |
|
|||||
|
2024
Q4 | $525K | Hold |
|
|||||
|
2024
Q3 | $825K | Hold |
|
|||||
|
2024
Q2 | $958K | Hold |
|
|||||
|
2024
Q1 | $1.22M | Buy |
|
|||||
|
2023
Q4 | $516K | Hold |
|
|||||
|
2023
Q3 | $346K | Hold |
|
|||||
|
2023
Q2 | $335K | Hold |
|
|||||
|
2023
Q1 | $272K | Hold |
|
|||||
|
2022
Q4 | $326K | Hold |
|
|||||
|
2022
Q3 | $234K | Hold |
|
|||||
|
2022
Q2 | $218K | Hold |
|
|||||
|
2022
Q1 | $266K | Hold |
|
|||||
|
2021
Q4 | $379K | Hold |
|
|||||
|
2021
Q3 | $500K | Hold |
|
|||||
|
2021
Q2 | $724K | Hold |
|
|||||
|
2021
Q1 | $724K | Hold |
|
|||||
|
2020
Q4 | $933K | Buy |
|